Legionella Testing Market Size & Growth Forecast 2026–2035, By Segments (Type, Test Method), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Legionella Testing Market size was around USD 325.49 Million in 2025 and is slated to grow at a 8.3% CAGR from 2026 to 2035, exceeding USD 722.47 Million by 2035. The industry revenue for 2026 is estimated at USD 349.22 million.

• Base Year Value (2025): USD 325.49 Million
• CAGR (2026-2035): 8.3%
• Forecast Year Value (2035): USD 722.47 Million
• Historical Data Period: 2022-2025
• Largest Region: Europe
• Forecast Period: 2026-2035

Legionella Testing Market Intelligence Snapshot:

• Regional Market Dynamics:

  • Europe held the largest share in 2025 due to established water safety oversight, routine monitoring practices, and recurring testing demand across commercial and public water systems.
  • Asia Pacific is forecast to expand at a 9.38% CAGR, supported by urban infrastructure growth, wider water monitoring adoption, and increasing testing needs across facilities.

• Segment Momentum:

  • Water Testing accounted for 73.73% of the market in 2025 because routine monitoring of water systems remains the primary approach for identifying contamination risks before potential exposure occurs.
  • Microbial Culture is the fastest-growing test method as users increasingly value direct organism recovery and confirmatory evidence for detailed environmental investigations and follow-up testing workflows.

• Market Expansion Drivers:

  • Rising incidence of Legionnaires disease outbreaks increasing demand for rapid legionella diagnostic testing solutions.
  • Expanding government public health surveillance programs strengthening routine water and environmental legionella monitoring.
  • Growing adoption of PCR-based pathogen detection technologies improving testing speed and diagnostic accuracy.

• Leading Market Participants:

  Leading players in the legionella testing market include Abbott Laboratories (United States), Danaher Corporation (United States), Becton, Dickinson and Company (United States), bioMérieux SA (France), F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc. (United States), QIAGEN N.V. (Netherlands), Bio-Rad Laboratories, Inc. (United States), Hologic, Inc. (United States), Takara Bio Inc. (Japan).

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2025 Market Size: USD 325.49 Million
  • 2026 Market Size: USD 15.2 billion
  • Projected Market Size: USD 722.47 Million by 2035
  • Growth Forecasts: 8.3% CAGR (2026-2035)

• Regional and Segment Outlook:

  • Leading Regional Market: Europe
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Water Testing (Type) | PCR (Test Method)
  • Emerging Opportunity Segment: IVD Testing (Type) | Microbial Culture (Test Method)

Market Growth Drivers and Industry Trends

Rising incidence of Legionnaires disease outbreaks increasing demand for rapid legionella diagnostic testing solutions

As reported outbreaks of Legionnaires disease draw closer scrutiny from hospitals, long-term care facilities, hotels, and large building operators, purchasing decisions in the legionella testing market increasingly favor methods that can identify contamination quickly enough to support immediate containment measures. The practical effect is a shift toward rapid diagnostic workflows for both clinical and water-system applications, since delayed confirmation can prolong exposure, complicate remediation, and raise legal and reputational risk for site operators. This dynamic is increasing demand for the market by making speed a central selection criterion, encouraging laboratories and environmental service providers to expand access to faster testing platforms and more responsive sampling programs.

Expanding government public health surveillance programs strengthening routine water and environmental legionella monitoring

Broader public health surveillance efforts are turning legionella monitoring from an occasional response activity into a more structured operational requirement for municipalities, healthcare campuses, commercial buildings, and industrial water systems. In the legionella testing market, this changes purchasing behavior by creating recurring testing volumes tied to compliance protocols, environmental assessments, outbreak prevention plans, and documentation requirements rather than one-time investigations alone. Regular sampling of cooling towers, potable water networks, and high-risk facilities supports market expansion by increasing reliance on accredited laboratories, standardized testing services, and monitoring contracts that align with government oversight expectations.

Growing adoption of PCR-based pathogen detection technologies improving testing speed and diagnostic accuracy

The spread of PCR-based methods is reshaping the legionella testing market by improving the tradeoff between turnaround time and result reliability, which has historically limited decision-making in water safety management. Faster and more sensitive detection allows laboratories, building managers, and infection control teams to identify contamination earlier, prioritize remediation, and verify corrective actions without waiting for longer culture-based processes. This is influencing market adoption by making molecular testing more attractive for high-risk environments where operational delays carry meaningful health and regulatory consequences, while also encouraging providers to invest in upgraded instrumentation, assay menus, and specialized testing capacity.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising incidence of Legionnaires disease outbreaks increasing demand for rapid legionella diagnostic testing solutions	2.00%	High	Europe, Asia Pacific	High	Near Term
Expanding government public health surveillance programs strengthening routine water and environmental legionella monitoring	1.70%	High	Europe, North America	High	Mid Term
Growing adoption of PCR-based pathogen detection technologies improving testing speed and diagnostic accuracy	1.40%	Moderate	Asia Pacific, Europe	Emerging	Mid Term

Regional Demand Dynamics

Europe (Largest Region) vs Asia Pacific (Fastest-Growing Region)

Europe held the largest regional share of the legionella testing market in 2025, supported by established water safety oversight, routine monitoring requirements, and a broad installed base of commercial, industrial, and public-use water systems that require recurring testing. Demand is aided by the practical need to monitor cooling towers, plumbing networks, healthcare facilities, hospitality sites, and municipal infrastructure where Legionella risk management is embedded into regular facility operations. This creates a steady testing cadence, with laboratories, building operators, and compliance-focused service providers sustaining high sample volumes across the region.

Asia Pacific is projected to expand at a 9.38% CAGR over the forecast period, with growth in the legionella testing market being propelled by expanding urban infrastructure, rising construction of large commercial buildings, and broader adoption of water quality monitoring across institutional and industrial settings. As more facilities add centralized cooling, complex plumbing, and higher-capacity water systems, routine pathogen testing becomes a more operational requirement rather than an occasional check. Growth is also being supported by increasing awareness of waterborne health risks, which is translating into stronger uptake of testing in hospitals, hotels, manufacturing sites, and high-density residential developments.

Regional Market Attractiveness & Strategic Fit Matrix
Parameter	North America	Asia Pacific	Europe	Latin America	MEA
Innovation Hub	Advanced	Developing	Advanced	Developing	Nascent
Cost-Sensitive Region	Medium	High	Medium	High	High
Regulatory Environment	Supportive	Neutral	Restrictive	Neutral	Neutral
Demand Drivers	Moderate	Moderate	Moderate	Weak	Weak
Development Stage	Developed	Developing	Developed	Emerging	Emerging
Adoption Rate	Medium	Medium	Medium	Low	Low
New Entrants / Startups	Moderate	Moderate	Moderate	Sparse	Sparse
Macro Indicators	Strong	Stable	Strong	Weak	Weak

Key Country Insights

United States

Water Safety Compliance

The U.S. legionella testing market is driven by routine monitoring across healthcare facilities, commercial buildings, and industrial water systems. Laboratories are prioritizing rapid detection methods and standardized testing workflows to support timely risk management and regulatory compliance.

Japan

Facility Hygiene Assurance

Japan focuses on Legionella testing as part of comprehensive building hygiene and water system maintenance programs. Organizations increasingly adopt reliable diagnostic methods that enable early contamination detection while supporting safe operation of public and commercial facilities.

South Korea

Rapid Detection Integration

South Korea is strengthening Legionella testing by incorporating faster diagnostic technologies into environmental monitoring programs. Demand is supported by heightened attention to water safety across hospitals, residential complexes, and large commercial infrastructure requiring regular surveillance.

Germany

Preventive Water Monitoring

Germany emphasizes preventive water quality management through consistent Legionella surveillance in public buildings and healthcare facilities. Testing providers are expanding validated laboratory capabilities and efficient sampling services to support compliance with established water hygiene standards.

France

Public Health Surveillance

France continues expanding Legionella testing across healthcare institutions, hospitality facilities, and municipal water systems to reinforce preventive public health practices. Market participants emphasize accredited laboratory services and dependable analytical accuracy to support routine monitoring requirements.

Italy

Building Water Management

Italy places strong emphasis on Legionella testing within hotels, hospitals, and public facilities where water quality management remains a key operational priority. Testing providers focus on practical monitoring solutions that facilitate regular inspections and effective contamination control.

Segment Leadership and Growth Trends

  Type Segment Analysis: Water Testing (Largest Segment) vs IVD Testing (Fastest-Growing Segment)

Water Testing held the dominant position in the legionella testing market in 2025, accounting for a 73.73% share. its position is anchored in the direct role that water systems play in legionella monitoring across commercial buildings, healthcare facilities, hospitality sites, and industrial environments. Since prevention efforts typically begin with routine surveillance of cooling towers, plumbing networks, and storage systems, water testing remains the most established and widely adopted approach in the legionella testing market. This sustained demand is reinforced by the operational need to identify contamination risks before exposure leads to broader public health and facility management concerns.

IVD Testing is emerging as the fastest-growing segment in the legionella testing market because end users increasingly need quicker clinical confirmation when infection is suspected. Growth is being supported by the practical advantage of testing methods that help link patient diagnosis with outbreak investigation and treatment decisions in a more time-sensitive setting than environmental screening alone. Compared with water testing, which is primarily preventive and surveillance-driven, IVD testing is gaining momentum from the rising need for rapid diagnostic support in clinical workflows where delayed identification can affect both patient management and containment measures.

Test Method Segment Analysis: PCR (Largest Segment) vs Microbial Culture (Fastest-Growing Segment)

By 2025, PCR represented the largest test method in the legionella testing market with a 44.52% share. Its market leadership is driven by the need for faster and more sensitive detection in environments where timely results shape remediation decisions and risk management actions. PCR fits well with routine monitoring programs because it can support quicker identification of legionella presence than slower traditional methods, making it especially practical for facilities that must manage water safety with minimal delay. This operational efficiency continues to sustain PCR adoption across the legionella testing market.

Microbial Culture is the fastest-growing test method in the legionella testing market as users continue to value methods that provide direct organism recovery and support confirmatory investigation. Its momentum is tied to situations where stakeholders require culture-based evidence for deeper environmental assessment, method validation, or follow-up analysis after an initial screening result. Relative to PCR, microbial culture is experiencing stronger uptake where the priority extends beyond rapid detection to include more detailed microbiological confirmation, giving it a stronger role in comprehensive testing workflows.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Type	Water Testing, IVD Testing	Water Testing	IVD Testing
Test Method	Microbial Culture, Direct Fluorescent Antibody (DFA) Stain, PCR, Others	PCR	Microbial Culture

Competitive Landscape and Market Positioning

Key companies in the legionella testing market:

1. Abbott Laboratories (United States)

2. Danaher Corporation (United States)

3. Becton Dickinson and Company (United States)

4. bioMérieux SA (France)

5. F. Hoffmann-La Roche Ltd. (Switzerland)

6. Thermo Fisher Scientific Inc. (United States)

7. QIAGEN N.V. (Netherlands)

8. Bio-Rad Laboratories Inc. (United States)

9. Hologic Inc. (United States)

10. Takara Bio Inc. (Japan)

Growing concerns regarding water safety and infection prevention are accelerating advancements in the legionella testing market. Companies are introducing rapid detection systems and highly sensitive analytical methods designed to improve testing efficiency and compliance with public health standards. Increased investment in automated testing workflows and environmental monitoring technologies is also supporting market expansion.

Industry Development/News

Company Name	Date	Key Development
LuminUltra Technologies	Sep-24	LuminUltra Technologies acquired the Legionella testing assets of Genomadix Inc., including the Genomadix Cube qPCR platform. This portable molecular diagnostic device allows for laboratory-grade Legionella detection in under one hour, significantly reducing turnaround times for onsite environmental and clinical water safety monitoring.
Ecolab	Nov-24	Ecolab acquired Barclay Water Management, incorporating its digital monitoring and monochloramine generation technologies into the Ecolab water-safety portfolio. This acquisition enhances the company's capability to provide continuous, automated Legionella risk management and water treatment solutions to institutional and industrial clients.
Aptamer Group	Jun-24	Aptamer Group partnered with Microsaic Systems to integrate Optimer binders into the Microtox platform. This collaboration focuses on developing a rapid Legionella detection solution, leveraging high-affinity binders to improve the sensitivity and speed of pathogen identification in water systems.
Bio-Rad Laboratories	Sep-22	Bio-Rad Laboratories received AFNOR validation for its iQ-Check Legionella PCR protocol. This certification provides independent regulatory confidence in the accuracy and reliability of the company’s molecular-based testing method, supporting its adoption for standardized Legionella surveillance and compliance in water safety programs.
Pace Analytical Services	Dec-21	Pace Analytical Services acquired Special Pathogens Laboratory to consolidate its position in the waterborne pathogen testing market. By integrating specialized expertise in Legionella detection and identification, the company expanded its suite of onsite and laboratory-based regulatory testing services for healthcare and industrial facilities.